13734 Federal Register / Vol. 60, No. 49 / Tuesday, March 14, 1995 / Notices

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing a change in

membership of the Durability Validation

of Composite NGV Fuel Cylinders

Program, and correcting an error in the

last notice published. The notification

was filed for the purpose of extending

the Act’s provisions limiting the

recovery of antitrust plaintiffs to actual

damages under specified circumstances.

Specifically, Southern California Gas

Company, Los Angeles, CA, has become

a party to the group research project.

Further, in the title of the August 31,

1994 notice published at 59 FR 45013,

the word ‘‘Valuation’’ should read

‘‘Validation’’.

No other changes have been made in

either the membership or planned

activity of the group research project.

Membership in the project remains

open, and SwRI intends to file

additional written notification

disclosing all changes in membership.

On July 12, 1994, SwRI filed its

original notification pursuant to Section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to Section 6(b) of the

Act on August 31, 1994, 59 FR 45013.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 95–6196 Filed 3–13–95; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Processes for the

Production of Steel From Iron Carbide

and Related Technologies

Notice is hereby given that, on

January 5, 1995, pursuant to Section 6(a)

of the National Cooperative Research

and Production Act of 1993, 15 U.S.C.

4301 et seq. (‘‘the Act’’), the parties to

a cooperative research and production

venture relating to processes for the

production of steel from iron carbide

and related technologies has filed a

notification simultaneously with the

Attorney General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specified

circumstances. Pursuant to Section 6(b)

of the Act, the identities of the parties

are: U.S. Steel Group, a unit of USX

Corporation, Pittsburgh, PA; Nucor

Corporation, Charlotte, NC; and Praxair,

Inc., Danbury, CT. None of the parties

are controlled by any other person. The

nature and objectives of the venture are

to jointly conduct a feasibility study of

a specific process for producing lowcarbon alloys (steel) from iron carbide

(the ‘‘Process’’). If the feasibility study is

successful, the venture will design,

construct and operate a plant to

demonstrate the feasibility of the

Process (the ‘‘Demonstration Plant’’).

The venture will involve the testing of

steel produced at the plant; the

collection, exchange and analysis of

research and production data and

information obtained from operating the

plant and concerning the Process, the

iron carbide processed and steel

produced at the plant; improvements

and modifications to the Process; and

development of related processes for the

production of steel from iron carbide.

The venture will also prosecute patent

applications (domestic and foreign)

covering the Process, improvements and

related processes, and will hold title to

such patents. The venture will license

its patents and unpatented technology

to third persons.

The parties have executed a Letter of

Intent, dated as of October 5, 1994,

which contemplates that they will enter

into a written definitive agreement

concerning the venture. No written

definitive agreement has yet been

executed.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 95–6195 Filed 3–13–95; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated November 21, 1994,

and published in the Federal Register

on November 29, 1994, (59 FR 61002),

Isotec, Inc., 3858 Benner Road,

Miamisburg, Ohio 45342, made

application to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Cathinone (1235) ......................... I

Methcathinone (1237) .................. I

N-Ethylamphetamine (1475) ........ I

N,N-Dimethylamphetamine (1480) I

Aminorex (1585) .......................... I

Methaqualone (2565) ................... I

Lysergic acid diethylamide (7315) I

Tetrahydrocannabinols (7370) ..... I

Mescaline (7381) ......................... I

2,5-Dimethoxyamphetamine

(7396).

I

3,4-Methylenedioxyamphetamine

(7400).

I

3,4-Methylenedioxy-Nethylamphetamine (7404).I

Drug Schedule

3,4-Methylenedioxymethamphetamine (7405).I

4-Methoxyamphetamine (7411) ... I

N-Ethyl-1-phenylcyclohexylamine

(7455).

I

Dihydromorphine (9145) .............. I

Normorphine (9313) ..................... I

Acetylmethadol (9601) ................. I

Alphacetylmethadol Except LevoAlphacetylmethadol (9603).I

Normethadone (9635) .................. I

3-Methylfentanyl (9813) ............... I

Amphetamine (1100) ................... II

Methamphetamine (1105) ............ II

Methylphenidate (1724) ............... II

Amobarbital (2125) ...................... II

Pentobarbital (2270) .................... II

Secobarbital (2315) ...................... II

1-Phenylcyclohexylamine (7460) . II

Phencyclidine (7471) ................... II

Phenylacetone (8501) .................. II

1-Piperidinocyclohexanecarbonitrile (8603).II

Codeine (9050) ............................ II

Dihydrocodeine (9120) ................. II

Oxycodone (9143) ....................... II

Hydromorphone (9150) ................ II

Benzoylecgonine (9180) .............. II

Ethylmorphine (9190) ................... II

Hydrocodone (9193) .................... II

Isomethadone (9226) ................... II

Meperidine (9230) ........................ II

Methadone (9250) ........................ II

Methadone intermediate (9254) ... II

Dextropropoxyphene, bulk (nondosage forms) (9273).II

Morphine (9300) ........................... II

Levo-Alphacetylmethadol (9648) . II

Oxymorphone (9652) ................... II

Fentanyl (9801) ............................ II

Comments were filed by two

registered manufacturers. The

comments were considered, however,

DEA determined that the application

should be approved. Therefore,

pursuant to Section 303 of the

Comprehensive Drug Abuse Prevention

and Control Act of 1970 and Title 21,

Code of Federal Regulations, Deputy

Assistant Administrator, Office of

Diversin Control, Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is approved and

registration is granted.

Dated: March 8, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–6218 Filed 3–13–95; 8:45 am]

BILLING CODE 4410–09–M